Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
BioMed Research International · 2024
DOI: 10.1155/2024/6673823 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von W Ray Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Peritonitis, Liver Cirrhosis, Albumins, Length of Stay. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Spontaneous bacterial peritonitis is a life‐threatening complication of cirrhosis that can increase healthcare utilization. The impact of albumin administration timing on hospital resource utilization and its optimal timing is unclear, despite its efficacy in improving survival for cirrhosis patients with spontaneous bacterial peritonitis. A retrospective study was conducted to evaluate the influence of the timing of albumin administration on the length of stay and total hospital cost for patients with cirrhosis and spontaneous bacterial peritonitis who require fluid resuscitation. The study utilized de‐identified data from Cerner Health Facts® data. Adult inpatients with a diagnosis of cirrhosis and SBP receiving ≥1 antibiotic and fluid resuscitation between January 1, 2009, and April 30, 2018, were included and stratified by albumin administration timing: ≤24 hours from hospital admission (“timely albumin”) or >24 hours of admission or no albumin (“non‐timely albumin”). We used a Kaplan‐Meier curve with log‐rank test to evaluate the association between timing of albumin administration and time to hospital discharge and a generalized linear model to examine the association between albumin timing and total hospital costs. We identified 1,308 hospitalizations, of which 301 contained valid cost data. The timely albumin group had a median time to discharge of 6.95 days compared to 7.78 days in the non‐timely group ( p = 0.02). Cost model showed that receiving timely albumin incurred 16% lower costs ( p = 0.027) than patients in the non‐timely albumin group. Timely albumin administration with an antibiotic regimen may shorten the length of stay and lower costs, thereby reducing hospital resource utilization in patients with cirrhosis and spontaneous bacterial peritonitis requiring fluid resuscitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology Stanford University, Stanford, CA, USA.
- Department of Anesthesiology Duke University, Durham, NC, USA.
- Department of Medicine Emory University, Atlanta, GA, USA.
- Grifols SSNA, Research Triangle Park, NC, USA.
- Boston Strategic Partners Inc., Boston, MA, USA.
ORCID-Profile: Kunal Lodaya
Zitieren
APA
Kim, W. R., Raghunathan, K., Martin, G. S., Davis, E. A., Sindhwani, N. S., Telang, S., & Lodaya, K. (2024). Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. BioMed Research International. https://doi.org/10.1155/2024/6673823
Vancouver
Kim WR, Raghunathan K, Martin GS, Davis EA, Sindhwani NS, Telang S, et al. Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. BioMed Research International. 2024. doi:10.1155/2024/6673823
BibTeX
@article{Kim2024,
author = {Kim, W Ray and Raghunathan, Karthik and Martin, Greg S and Davis, E Anne and Sindhwani, Navreet Sandhu and Telang, Santosh and Lodaya, Kunal},
title = {Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis},
journal = {BioMed Research International},
year = {2024},
doi = {10.1155/2024/6673823}
}
EUVIMED